New Lancet paper looks at heart safety for orforglipron, the small-molecule GLP-1 pill, in people with type 2 diabetes.
Recap by typeshit. Full story at The Lancet.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
The surgeon flags risks he sees in using the so-called Barbie peptide for tanning, saying men in particular should be careful.
Targets include Astra Peptides, Texas Peptides and Striker Pharmacy. Lilly says it has referred over 200 people and businesses to the FDA, DOJ and state attorneys general.
Loading…